Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
Kobayashi S, Bando H, Taketomi A, Takamoto T, Shinozaki E, Shiozawa M, Hara H, Yamazaki K, Komori K, Matsuhashi N, Kato T, Kagawa Y, Yokota M, Oki E, Komine K, Takahashi S, Wakabayashi M, Yoshino T. Kobayashi S, et al. Among authors: oki e. BMC Cancer. 2023 Aug 21;23(1):779. doi: 10.1186/s12885-023-11311-5. BMC Cancer. 2023. PMID: 37605122 Free PMC article. Clinical Trial.
Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case.
Fukuhara T, Egashira A, Imamura M, Ikegami T, Oki E, Soejima Y, Sadanaga N, Taketomi A, Yao T, Morita M, Kakeji Y, Tsuneyoshi M, Maehara Y. Fukuhara T, et al. Among authors: oki e. Surg Today. 2009;39(1):59-63. doi: 10.1007/s00595-008-3779-6. Epub 2009 Jan 8. Surg Today. 2009. PMID: 19132471
Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
Oki E, Emi Y, Kojima H, Higashijima J, Kato T, Miyake Y, Kon M, Ogata Y, Takahashi K, Ishida H, Saeki H, Sakaguchi Y, Yamanaka T, Kono T, Tomita N, Baba H, Shirabe K, Kakeji Y, Maehara Y. Oki E, et al. Int J Clin Oncol. 2015 Aug;20(4):767-75. doi: 10.1007/s10147-015-0784-9. Epub 2015 Jan 28. Int J Clin Oncol. 2015. PMID: 25627820 Clinical Trial.
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study.
Baba H, Baba Y, Uemoto S, Yoshida K, Saiura A, Watanabe M, Maehara Y, Oki E, Ikeda Y, Matsuda H, Yamamoto M, Shimada M, Taketomi A, Unno M, Sugihara K, Ogata Y, Eguchi S, Kitano S, Shirouzu K, Saiki Y, Takamori H, Mori M, Hirata T, Wakabayashi G, Kokudo N. Baba H, et al. Among authors: oki e. Oncotarget. 2015 Oct 20;6(32):34004-13. doi: 10.18632/oncotarget.5227. Oncotarget. 2015. PMID: 26372896 Free PMC article.
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.
Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y, Fukunaga T, Gotoh M, Emi Y, Yoshida K, Oki E, Takahashi S, Kuriki H, Sato K, Sasako M. Fuse N, et al. Among authors: oki e. Gastric Cancer. 2017 Mar;20(2):332-340. doi: 10.1007/s10120-016-0606-4. Epub 2016 Mar 8. Gastric Cancer. 2017. PMID: 26956689 Free PMC article. Clinical Trial.
618 results